James P. Murphy v. Reed Williams

430 S.W.3d 613, 2014 WL 1779818, 2014 Tex. App. LEXIS 4842
CourtCourt of Appeals of Texas
DecidedMay 5, 2014
Docket05-12-01730-CV
StatusPublished
Cited by4 cases

This text of 430 S.W.3d 613 (James P. Murphy v. Reed Williams) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
James P. Murphy v. Reed Williams, 430 S.W.3d 613, 2014 WL 1779818, 2014 Tex. App. LEXIS 4842 (Tex. Ct. App. 2014).

Opinion

OPINION

Opinion by

Justice FITZGERALD.

This case involves claims of tortious interference and the Real Estate License Act (“RELA”). In two issues, James Murphy, a licensed real estate broker, asserts the trial court erred in granting summary judgment in favor of Reed Williams because RELA does not preclude his tortious interference claims and he raised a fact issue on these claims. Because Williams is not a licensed broker and did not act as a broker, we conclude RELA bars Murphy’s tortious interference claims. Therefore, the trial court did not err in granting summary judgment. The trial court’s judgment is affirmed.

BACKGROUND

The dispute in this case arises out of the sale of five tracts of improved and unimproved real property in the Frisco Medical Center subdivision (the “Property”) to Healthcare Realty Trust (“HRT”) for $133.5 million dollars and Murphy’s claim that he is entitled to compensation for brokering the transaction.

Murphy is a licensed real estate broker and a principal in JPM Realty Property Management, Inc. (“JPM”). Prior to the sale at issue, the Property was owned by four limited partnerships: Frisco POB II Limited, Frisco Surgery Center Limited, Frisco POB I Limited, and Medland, L.P. (collectively, the “Sellers”). Texas Land Management LLC (“TLM”) is the general partner of the Sellers. Jim Williams (“Williams Sr.”) is the president and man *615 aging partner of TLM. His son, Reed Williams (‘Williams”), is vice president of TLM. Land Plan Development Corp. (“Land Plan”) is also an affiliate of the Sellers. Williams Sr. is the president of Land Plan and Williams serves as its vice president and director of medical development.

In 2010, Murphy was working with the Sellers to secure refinancing for loans secured by liens on the Property. When Murphy learned that the Sellers were willing to market the Property for sale on a limited basis, he approached Williams Sr. about an exclusive written listing agreement. Williams Sr. advised that the Sellers would not authorize a listing agreement for a commission, but indicated he would allow Murphy to market the property on a limited basis in accordance with guidelines dictated by Williams Sr.

Under these guidelines, Murphy was permitted to market the Property to only one prospect at a time as approved by Williams Sr. Murphy initially chose to market the Property to Rainier Capital Markets, LLC (“RCM”). In connection with RCM’s contemplated purchase, RCM was required to enter into a nondisclosure agreement with Land Plan. The agreement required that the information and materials provided by Land Plan would be solely for the purpose of evaluating a possible transaction and would be maintained as confidential.

At some juncture, another entity, Rainier Medical Investments (“RMI”) became involved with Murphy. The record is unclear as to what relationship, if any, exists between RCM and RMI, other than Williams Sr.’s sworn statement that they are separate companies.

It is generally agreed that Murphy marketed the Property to RCM as authorized. Williams Sr. told Murphy that notwithstanding the Sellers’ refusal to enter into a listing agreement with him, Williams Sr. would recommend that Murphy receive a commission if the sale of the Property was consummated.

In late October 2010, Murphy informed Williams Sr. that RCM was not going to purchase the Property. Williams Sr. consented to the substitution of a new prospective purchaser, AmeriMed. Accordingly, AmeriMed and Land Plan entered into a nondisclosure agreement.

Prior to any involvement in the transaction at issue, RMI had been engaged in discussions with HRT about a partnership in a different real estate development on Flower Mound, Texas. RMI and HRT entered into a confidentiality agreement in which RMI agreed to provide HRT with information and analysis concerning acquisition and development opportunities.

At some point in mid-November 2010, without Williams Sr.’s knowledge or approval, RMI contacted HRT about the sale of the Property and provided Seller’s confidential information. It appears that RMI obtained this information through RCM. HRT had never been approved as a prospective buyer, and Williams Sr. did not authorize Murphy to consent to RMI providing information to HRT.

In late November, HRT contacted Williams to express an interest in purchasing the Property. Williams asked Williams Sr. for permission to provide confidential information to HRT, and Williams Sr. consented. HRT executed a nondisclosure agreement, and Land Plan, on behalf of the Sellers, began providing financial information to HRT.

An HRT representative made arrangements through Williams to meet with Williams Sr. Murphy subsequently contacted Williams Sr. and claimed that HRT was his prospect, and that he had arranged the meeting.

*616 The sale of the Property to HRT was consummated on December 29, 2010. The purchase agreement does not provide for the payment of a brokerage commission to Murphy, JPM, or any other entity or individual.

After he was denied a commission, Murphy, joined by RMI and JPM (collectively, “Plaintiffs”) sued HRT, the Sellers, TLM, Land Plan, Land Plan Medical, L.P. (the latter two together, the “Land Plan Defendants”), Williams Sr. and Williams (all defendants collectively, “Defendants”) on various causes of action, including breach of contract, unfair competition, fraud, es-toppel, quantum meruit, conspiracy, and tortious interference.

Murphy’s claims against HRT were subsequently settled. Following a period of discovery, Defendants moved for traditional and no-evidence summary judgment on all of Plaintiffs’ claims. On October 12, 2012, the trial court granted the motion against Plaintiffs in favor of Defendants. The trial court also granted a motion to sever Murphy’s claims against the Defendants from the original action. 1 This appeal involves only Murphy’s tortious interference claims against Williams.

ANALYSIS

In his first issue, Murphy asserts the trial court erred in granting summary judgment on his tortious interference claims because Williams acted a broker and RELA does not preclude a broker’s tortious interference claim against another broker. Williams responds that summary judgment was appropriate because he did not act as a broker in connection with the sale of the Property.

Defendants moved for both a traditional and no-evidence summary judgment on the tortious interference claim. We review a trial court’s summary judgment de novo. Travelers Ins. Co. v. Joachim, 815 S.W.3d 860, 862 (Tex.2010). The standards of review for traditional and no-evidence summary judgments are well-known. Beal Bank v. Gilbert, 417 S.W.3d 704, 707-08 (Tex.App.-Dallas 2013, no pet.). With respect to a traditional motion for summary judgment, the movant has the burden to demonstrate that no genuine issue of material fact exists, and it is entitled to judgment as a matter of law. Tex.R. Civ. P. 166a(c); Nixon v. Mr. Prop. Mgmt. Co.,

Related

Cite This Page — Counsel Stack

Bluebook (online)
430 S.W.3d 613, 2014 WL 1779818, 2014 Tex. App. LEXIS 4842, Counsel Stack Legal Research, https://law.counselstack.com/opinion/james-p-murphy-v-reed-williams-texapp-2014.